848. What's Brewing with Ibrutinib?
Session: Symposium: Novel Clinical Risks for Fungal Disease
Thursday, October 4, 2018: 2:00 PM
Room: W 2014-2016
Gil Redelman-Sidi, MD, Memorial Sloan Kettering Cancer Center, New York, NY

b>Gil Redelman-Sidi
redelmansidi@hotmail.com
6 East 97th Street, Apt 5c
New-York, NY, 10029
1-212-828-0681
Education
01/1996 - 04/2000
Sackler School of Medicine, Tel-Aviv University, Israel
MD, 06 / 2000
10/1992 - 01/1996
Sackler School of Medicine, Tel-Aviv University, Israel
Medical Sciences
Bachelor of Medical Sciences, 03 / 1997
Medical School Honors/Awards
Dean's List for Academic Achievements in the academic year 1995/96
Work Experience
07/2008 - present
MEMORIAL SLOAN KETTERING CANCER CENTER
Fellow, Infectious Diseases
07/2007 - 06/2008
JACOBI MEDICAL CENTER, ALBERT EINSTEIN COLLEGE OF MEDICINE
Chief Resident, Medicine
07/2004 - 06/2007
JACOBI MEDICAL CENTER, ALBERT EINSTEIN COLLEGE OF MEDICINE
Resident, Medicine
06/2003 - 05/2004
ISRAELI DEFENSE FORCE
Captain, Head of the Public Inquiries Department, Surgeon General Headquarters
02/2002 - 06/2003
ISRAELI DEFENSE FORCE
Captain, Armour Corps School Infirmary Commander
10/2000 - 02/2002
ISRAELI DEFENSE FORCE
Lieutenant, Armoured Battalion Medical Officer
Research Experience
10/2008 - Present
Memorial Sloan Kettering Cancer Center
Michael Glickman, MD, PhD
DNA repair mechanisms in Mycobacterium smegmatis
07/2005 - 06/2007
Albert Einstein College of Medicine
Arturo Casadevall, MD, PhD
In-vitro and the in-vivo mutation rate of Cryptococcus neoformans
Books and Chapters
Gil Sidi, Eli Schwartz. Relapsing Fever. Chapter 19 in: Schwartz E. Tropical Diseases in Travelers. July 2009, Wiley-Blackwell.
Publications
Sidi G, Davidovitch N, Balicer RD, Anis E, Grotto I, Schwartz E. Tickborne relapsing fever in Israel. Emerg Infect Dis. 2005 Nov;11(11):1784-6
Sidi G, Shinar Y, Livneh A, Langevitz P, Pras M, Pras E. Protracted febrile myalgia of familial Mediterranean fever. Mutation analysis and clinical correlations. Scand J Rheumatol. 2000;29(3):174-6



Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.